Exacerbating Pressure Overload-Induced Cardiac Hypertrophy: Novel Role of Adaptor Molecule Src Homology 2-B3

Hypertension

Volumn 66, Issue 3, 2015, Pages 571-581

  Zhu, Xuehai ^a   Fang, Jing ^a   Jiang, Ding Sheng ^b   Zhang, Peng ^b   Zhao, Guang Nian ^b   Zhu, Xueyong ^b   Yang, Ling ^b   Wei, Xiang ^a   Li, Hongliang ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

aortic banding; cardiomegaly; knockout rats; LNK protein, mouse; TALEN

Indexed keywords

ADAPTOR PROTEIN; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; COLLAGEN; FOCAL ADHESION KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; GREEN FLUORESCENT PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; SRC HOMOLOGY 2 B3 PROTEIN; UNCLASSIFIED DRUG; LNK PROTEIN, MOUSE; ONCOPROTEIN; SHB PROTEIN, RAT; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOMEGALY; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; FIBROSING ALVEOLITIS; FOLLOW UP; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RATE; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; LUNG CONGESTION; LUNG WEIGHT; MOUSE; NEWBORN; NONHUMAN; NULL ALLELE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; GENETICS; HEART MUSCLE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS; RATS; SIGNAL TRANSDUCTION;

EID: 84939243523     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05183     Document Type: Article

References (41)

1. Zhao GN, Jiang DS, Li H. Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. Biochim Biophys Acta. 2015;1852:365-378. doi: 10.1016/j.bbadis.2014.04.030.
2. Jiang DS, Wei X, Zhang XF, et al. IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun. 2014;5:3303. doi: 10.1038/ncomms4303.
3. Jiang DS, Li L, Huang L, Gong J, Xia H, Liu X, Wan N, Wei X, Zhu X, Chen Y, Chen X, Zhang XD, Li H. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload. Hypertension. 2014;64:77-86. doi: 10.1161/HYPERTENSIONAHA.114.03229.
4. Tong W, Lodish HF. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med. 2004;200:569-580. doi: 10.1084/ jem.20040762.
5. Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A, Paige CJ, Pawson T. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med. 2002;195:1599-1611.
6. Takaki S, Sauer K, Iritani BM, Chien S, Ebihara Y, Tsuji K, Takatsu K, Perlmutter RM. Control of B cell production by the adaptor protein lnk. Definition of a conserved family of signal-modulating proteins. Immunity. 2000;13:599-609.
7. Gery S, Koeffler HP. Role of the adaptor protein LNK in normal and malignant hematopoiesis. Oncogene. 2013;32:3111-3118. doi: 10.1038/ onc.2012.435.
8. Devallière J, Chatelais M, Fitau J, Gérard N, Hulin P, Velazquez L, Turner CE, Charreau B. LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets parvin to control cell adhesion and migration. FASEB J. 2012;26:2592-2606. doi: 10.1096/fj.11-193383.
9. Takizawa H, Nishimura S, Takayama N, et al. Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. J Clin Invest. 2010;120:179-190. doi: 10.1172/JCI39503.
10. Devallière J, Charreau B. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling. Biochem Pharmacol. 2011;82:1391-1402. doi: 10.1016/ j.bcp.2011.06.023.
11. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-687. doi: 10.1038/ ng.384.
12. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41:342-347. doi: 10.1038/ng.323.
13. Ikram MK, Sim X, Xueling S, et al; Global BPgen Consortium. Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet. 2010;6:e1001184. doi: 10.1371/journal. pgen.1001184.
14. Kullo IJ, Shameer K, Jouni H, Lesnick TG, Pathak J, Chute CG, de Andrade M. The ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study. Front Genet. 2014;5:166. doi: 10.3389/fgene.2014.00166.
15. Grossman W, Haynes F, Paraskos JA, Saltz S, Dalen JE, Dexter L. Alterations in preload and myocardial mechanics in the dog and in man. Circ Res. 1972;31:83-94.
16. Wang Y. Mitogen-activated protein kinases in heart development and diseases. Circulation. 2007;116:1413-1423. doi: 10.1161/ CIRCULATIONAHA.106.679589.
17. Lin DC, Yin T, Koren-Michowitz M, Ding LW, Gueller S, Gery S, Tabayashi T, Bergholz U, Kazi JU, Rönnstrand L, Stocking C, Koeffler HP. Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3. Blood. 2012;120:3310-3317. doi: 10.1182/blood-2011-10-388611.
18. Simon C, Dondi E, Chaix A, de Sepulveda P, Kubiseski TJ, Varin-Blank N, Velazquez L. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells. Blood. 2008;112:4039-4047. doi: 10.1182/blood-2008-05-154849.
19. Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epodependent JAK2 activation and downstream signaling pathways. Blood. 2005;105:4604-4612. doi: 10.1182/blood-2004-10-4093.
20. Seita J, Ema H, Ooehara J, Yamazaki S, Tadokoro Y, Yamasaki A, Eto K, Takaki S, Takatsu K, Nakauchi H. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci U S A. 2007;104:2349-2354. doi: 10.1073/pnas.0606238104.
21. Liu Y, Jiang XL, Liu Y, Jiang DS, Zhang Y, Zhang R, Chen Y, Yang Q, Zhang XD, Fan GC, Li H. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice. Cardiovasc Res. 2014;101:87-96. doi: 10.1093/cvr/cvt232.
22. Chen K, Gao L, Liu Y, Zhang Y, Jiang DS, Wei X, Zhu XH, Zhang R, Chen Y, Yang Q, Kioka N, Zhang XD, Li H. Vinexin- protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway. Basic Res Cardiol. 2013;108:338. doi: 10.1007/s00395-013-0338-0.
23. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem. 2001;276:27462-27469. doi: 10.1074/jbc.M102940200.
24. Franchini KG. Focal adhesion kinase-the basis of local hypertrophic signaling domains. J Mol Cell Cardiol. 2012;52:485-492. doi: 10.1016/ j.yjmcc.2011.06.021.
25. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1995;92:11618-11622.
26. Bersenev A, Wu C, Balcerek J, Tong W. Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest. 2008;118:2832-2844. doi: 10.1172/JCI35808.
27. Gueller S, Goodridge HS, Niebuhr B, Xing H, Koren-Michowitz M, Serve H, Underhill DM, Brandts CH, Koeffler HP. Adaptor protein Lnk inhibits c-Fms-mediated macrophage function. J Leukoc Biol. 2010;88:699-706. doi: 10.1189/jlb.0309185.
28. Takizawa H, Eto K, Yoshikawa A, Nakauchi H, Takatsu K, Takaki S. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine-and integrinmediated signals. Exp Hematol. 2008;36:897-906. doi: 10.1016/j. exphem.2008.02.004.
29. Tashiro K, Omori M, Kawabata K, Hirata N, Yamaguchi T, Sakurai F, Takaki S, Mizuguchi H. Inhibition of Lnk in mouse induced pluripotent stem cells promotes hematopoietic cell generation. Stem Cells Dev. 2012;21:3381-3390. doi: 10.1089/scd.2012.0100.
30. Ding LW, Sun QY, Lin DC, et al. LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene. 2015;34:1463-1474. doi: 10.1038/ onc.2014.34.
31. Hannigan GE, Coles JG, Dedhar S. Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ Res. 2007;100:1408-1414. doi: 10.1161/01.RES.0000265233.40455.62.
32. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R, Dedhar S. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem. 2003;278:22374-22378. doi: 10.1074/jbc.M303083200.
33. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A. 1998;95:11211-11216.
34. Lu H, Fedak PW, Dai X, Du C, Zhou YQ, Henkelman M, Mongroo PS, Lau A, Yamabi H, Hinek A, Husain M, Hannigan G, Coles JG. Integrinlinked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation. 2006;114:2271-2279. doi: 10.1161/CIRCULATIONAHA.106.642330.
35. Wickström SA, Lange A, Montanez E, Fässler R. The ILK/PINCH/ parvin complex: the kinase is dead, long live the pseudokinase! EMBO J. 2010;29:281-291. doi: 10.1038/emboj.2009.376.
36. Franchini KG, Torsoni AS, Soares PH, Saad MJ. Early activation of the multicomponent signaling complex associated with focal adhesion kinase induced by pressure overload in the rat heart. Circ Res. 2000;87:558-565.
37. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1994;91:10148-10152.
38. Clemente CF, Xavier-Neto J, Dalla Costa AP, Consonni SR, Antunes JE, Rocco SA, Pereira MB, Judice CC, Strauss B, Joazeiro PP, Matos-Souza JR, Franchini KG. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways. J Mol Cell Cardiol. 2012;52:493-501. doi: 10.1016/j.yjmcc.2011.10.015.
39. Takizawa H, Kubo-Akashi C, Nobuhisa I, Kwon SM, Iseki M, Taga T, Takatsu K, Takaki S. Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood. 2006;107:2968-2975. doi: 10.1182/blood-2005-05-2138.
40. Abbott A. Laboratory animals: the renaissance rat. Nature. 2004;428:464-466. doi: 10.1038/428464a.
41. Ruhnke M, Ungefroren H, Zehle G, Bader M, Kremer B, Fändrich F. Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages. Stem Cells. 2003;21:428-436. doi: 10.1634/stemcells.21-4-428.